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Meckel syndrome (MKS) is a rare autosomal recessive lethal condition characterized by central nervous system malfor-
mations, polydactyly, multicystic kidney dysplasia, and ductal changes of the liver. Three loci have been mapped (MKS1–
MKS3), and two genes have been identified (MKS1/FLJ20345 and MKS3/TMEM67), whereas the gene at the MKS2 locus
remains unknown. To identify new MKS loci, a genomewide linkage scan was performed using 10-cM–resolution mi-
crosatellite markers in eight families. The highest heterogeneity LOD score was obtained for chromosome 12, in an
interval containing CEP290, a gene recently identified as causative of Joubert syndrome (JS) and isolated Leber congenital
amaurosis. In view of our recent findings of allelism, at the MKS3 locus, between these two disorders, CEP290 was
considered a candidate, and homozygous or compound heterozygous truncating mutations were identified in four fam-
ilies. Sequencing of additional cases identified CEP290 mutations in two fetuses with MKS and in four families presenting
a cerebro-reno-digital syndrome, with a phenotype overlapping MKS and JS, further demonstrating that MKS and JS can
be variable expressions of the same ciliopathy. These data identify a fourth locus for MKS (MKS4) and the CEP290 gene
as responsible for MKS.
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Meckel syndrome (MKS [MIM 249000]) is an autosomal
recessive lethal condition characterized by the association
of CNS malformations (typically occipital meningoen-
cephalocele), postaxial polydactyly (PD), multicystic kid-
ney dysplasia, and ductal proliferation in the portal area
of the liver. In addition, the clinicopathological diver-
sity of MKS phenotypes has led to the distinction of
Meckel-like syndrome, or Goldston syndrome groups
(MIM 267010). MKS is genetically heterogeneous, and two
genes have been identified—MKS1 on 17q1 and TMEM67
(MKS3) on 8q,2 which encode proteins required for pri-
mary cilium formation3—whereas MKS2 at 11q13 remains
unknown.4 Each of these three loci accounts for ∼10% of
cases,5 which suggests the existence of further genetic
heterogeneity.
To identify new MKS loci, a genomewide scan was per-
formed in eight families unlinked to MKS1, MKS2, or MKS3
loci, with use of microsatellite markers spaced 10 cM apart.
The highest heterogeneity LOD (HLOD) score was found
at marker D12S326 ( ; proportion of linkedHLODp 2.45
familie ) (fig. 1a and 1b). Five affected siblings fromsp 0.6
four consanguineous families showed homozygosity for
two consecutive microsatellite markers on chromosome
12 (families 1, 2, 11, and 12) (fig. 1c). In family 3, parents
were not reported to be related but originated from the
same region (Gabes and Mareth) of southern Tunisia. The
two affected siblings were therefore analyzed by Affymet-
rix 10K SNP chips (version 2.1), and only a single common
homozygous region was observed, on a 10-Mb interval on
chromosome 12q21 (29 consecutive SNPs) (fig. 2a). Hap-
Figure 1. Genomewide scan. a, Results of the multipoint linkage analysis with microsatellite markers performed in eight families
(Fam), with use of MERLIN software6 under the assumption of a fully penetrant recessive model with a disease-allele of frequency of
0.0001 and with allowance for heterogeneity between families. The highest HLOD score (2.45) was found at marker D12S326. b, Summary
of HLOD observed at chromosome 12 in each of the eight families. Six of the eight families show a LOD score at marker D12S326,
D12S351, or D12S346 close to its maximal value (LODmax). c, Haplotyping at the 12q21 locus in the six families showing potential
linkage to chromosome 12. Homozygosity for two consecutive markers—D12S326 and D12S351 (boxed)—is observed in five affected
siblings of four families (1, 2, 11, and 12). In family 1, the first child and case 6 (gray) are affected with ARPKD.
172 The American Journal of Human Genetics Volume 81 July 2007 www.ajhg.org
Figure 2. Haplotype analysis of families 3 and 4. a, Haplotyping analysis with Affymetrix 10K SNP chips of affected siblings 335 and
336 of family 3, which identified a single homozygous region on chromosome 127 between markers rs1882186 and rs1389064. This 10-
Mb region includes CEP290. b, Analysis of four microsatellite markers flanking CEP290 in family 3, which confirmed homozygosity in
only affected siblings 335 and 336 and reduced the telomeric boundary of the interval to position 88.71 (D12S1678). In family 4
carrying the same maternally inherited p.Asp128GlufsX34 mutation as family 3, the maternal disease haplotype is different from fetuses
335 and 336 and does not suggest a founder effect for the mutation. Positions of SNP and microsatellite markers are given according
to the UCSC Genome Browser database.
lotype analysis with microsatellite markers flanking CEP290
confirmed homozygosity in fetuses but not in unaffected
siblings and reduced the telomeric boundary to posi-
tion 88.7 Mb (fig. 2b). This smallest interval of 8 Mb con-
tained CEP290, a gene encoding a centrosomal protein
recently identified as the Joubert syndrome (JS [MIM
213300]) gene at the JBTS5 locus,8,9 also found to be fre-
quently mutated in isolated Leber congenital amaurosis
(LCA [MIM 204000]).10,11 JS is another autosomal recessive
ciliopathy, characterized by a combination of neurological
signs12 and a “molar tooth sign” (MTS) on axial images
that is associated with cerebellar vermis hypoplasia/dys-
plasia.13 Variable features include retinal dystrophy, renal
anomalies, PD, and occipital encephalocele (OE) defining
the JS-related disorders or cerebello-oculo-renal syndrome
(CORS). Mutations/deletions in three genes have been
identified as responsible for JS: AHI1 (JBTS3, 6q23.2),14
NPHP1 (JBTS4, 2q13),15 and CEP290 (JBTS5, 12q21),8,9
whereas two more genes remain unknown: JBTS1/CORS1
at 9q34.316 and JBTS2/CORS2 at 11p12-11q13.3.17,18
In view of the phenotypic overlap between JS and MKS
and our recent finding of allelism at the MKS3 locus be-
tween these two disorders,19 CEP290 was considered an
excellent candidate gene. Sequencing of the 53 coding
exons revealed homozygous truncating mutations in fam-
ilies 1, 2, and 3 and compound heterozygous mutations
in family 4, confirming that CEP290 is the gene for MKS
on chromosome 12. Sequencing of 20 additional MKS
cases (all negative for mutations in MKS1 and TMEM67)
identified two additional MKS-affected families with af-
fected individuals carrying compound heterozygous mu-
tations of CEP290 (families 5 and 6). Finally, we identified
mutations in four families presenting a cerebro-reno-dig-
ital syndrome, with a phenotype between that of MKS and
JS and thus representing the continuum spectrum between
these two disorders (families 7–10). Clinical data are sum-
marized in table 1, and mutations are shown in figure 3.
In families 1–6, when autopsy was performed, MKS was
diagnosed for all fetuses on the basis of the association of
a brain malformation, MKS cystic kidneys (fig. 4a–4d), and
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bile-duct proliferation (BDP) of liver (table 1 and fig. 4e–
4h). occipital meningocele (OM) was present in at least
one sibling in 5 of 6 families, which was associated with
a Dandy-Walker malformation (DWM) or vermis agenesis
in some cases. In all siblings of family 3 and in subject 4
of family 1, the DWM was the only brain malformation.
Detailed neuropathological examination of seven cases as-
sumed to have DWM showed brain-stem disorganization
in addition to the severe cerebellar vermis hypoplasia (ta-
ble 1 and fig. 4i–4k). Transverse sections at the level of the
pons showed elongated and thickened peduncles resulting
in an inverted molar tooth aspect in four subjects (table
1 and fig. 4k). In subject 3501, the fourth ventricle (V4)
distortion/dilatation was more severe, and no MTS was
observed (fig. 4j). Among the other signs and with con-
sideration of the affected siblings for whom no DNA was
available, PD was present in two of six families (6 of 14
subjects), intrauterine growth retardation (IUGR) affected
one subject (subject 4), situs inversus and asplenia were
present in one fetus (fetus 408), microphthalmia was pre-
sent in one fetus (fetus 312), and cardiac septal defects
were present in two fetuses (fetuses 0114 and 650).
In addition to these six fetuses with MKS, CEP290 mu-
tations were identified in four families (families 7–10)
whose conditions were considered “Meckel-like” because
of the absence of at least one characteristic feature re-
quired for the diagnosis of MKS. In fetus 385 of family 7,
no BDP of liver was observed. In family 8, the molecular
screening was performed despite heterozygosity at the
CEP290 locus in fetus 712 from consanguineous Palestin-
ian parents. At histology, the fetus, at 18 wk gestation,
presented cystic kidneys with liver ductal plate prolifer-
ation characteristic of MKS but with an isolated vermis
hypoplasia as brain malformation. In families 9 and 10,
which each had two affected siblings, a DWM that was
associated with OE was present in one sibling but not the
other. At neuropathological examination, however, major
abnormalities of the brain stem and the cerebellum were
present in all four fetuses, with thickened cerebellar pe-
duncles, severe vermis hypoplasia, and disorganized cor-
ticospinal tracts at the pons level (fig. 4p and 4q). Kidneys
were macroscopically normal in family 9, with microcystic
formations involving mainly the medullary collecting
tubes at histology (fetus 381 [fig. 4l]), and were charac-
teristic of MKS in family 10 (fetus 05/158 [fig. 4m]). The
liver was either unremarkable (fetus 380) or showed mod-
erate/focal ductal plate anomalies (fetus 381 [fig. 4n] and
fetus 05/158 [fig. 4o]). Postaxial PD was present in fetuses
385 and 380, and no other visceral malformation was
observed.
The mutations were all nonsense, frameshift, or splice-
site mutations, predicting a truncated protein in absence
of RNA-mediated decay. Interestingly, the p.Asp128Glufs-
X34 mutation, homozygous in the patients from Tunisian
family 3, was also found but in the heterozygous state in
the fetus from family 4, where it was inherited from the
mother of French origin. Haplotyping by microsatellite
markers at the CEP290 locus showed that different alleles
(fig. 2b) were associated with this mutation, suggesting a
recurrent mutation rather than a founder effect. This mu-
tation was also reported in a patient with LCA.11 Therefore,
a mutational hotspot may exist at this position. Another
possible mutational hotspot at 3175A or nearby could also
be suggested. A deletion (c.3175delA) was identified in
Tunisian family 2, whereas an insertion of a single A at
the same position was identified in two patients originat-
ing from Denmark8 and France,11 and a T deletion at the
next base (c.3176delT) was found in a Turkish patient with
JS.20 The p.Leu1884ThrfsX23 mutation identified in family
6 was reported elsewhere in three families of French
origin11,21 and one German family.8 In addition, the com-
pound heterozygous mutation in family 6 (p.Leu1884-
ThrfsX23p.Phe1950LeufsX15) was also present in a liv-
ing patient with JS reported by Tory et al.21
In MKS, the most common CNS malformations in-
clude posterior OE, prosencephalic dysgenesis, and rhom-
bic roof dysgenesis.22 However, other malformations, such
as DWM, hydrocephalus, and agenesis of the corpus cal-
losum, are described as occasional features. Diagnosis of
DWM is based on vermis hypoplasia/agenesis and cystic
dilatation of the V4. Vermis hypoplasia/agenesis and V4
dilatation may also be features of MTS, which is consid-
ered characteristic of JS. In fetuses, the distinction between
these two malformations is not easy to discern. MTS is
characterized by hypoplastic brain stem and dysmorphic
V4, flanked laterally with thick cerebellar peduncle. The
V4 is usually moderately dilated. The vermis is severely
hypoplastic, reduced to a few folia. In all cases reported
here, the brain malformation initially reported as DWM
consisted, after careful neuropathological examination, of
a severe vermis hypoplasia with brain-stem dysplasia. In
eight fetuses, the malformation was associated with OE or
OM.
Fetal cases with an incomplete phenotype such as iso-
lated vermis hypoplasia (family 7), normal brain with few
tubular medullary cysts (family 9), or normal or discrete
liver changes (families 6, 9, and 10) are regrouped in a
clinically heterogeneous group of disorders referred to as
“Meckel-like syndrome.” We recently showed a kidney phe-
notypic overlap between MKS and Bardet-Biedl syndrome
(BBS [MIM 209900]), another recessive disorder ascribed
to a ciliary function defect.23 More recently, we found that
MKS-like–affected subjects could carry TMEM67 gene mu-
tations and that TMEM67 was also a disease-causing gene
for JS.19 Here, we report 10 cases of CEP290-mutated fe-
tuses, with a continuum of clinical 2spectrum from JS to
MKS, with either the brain malformation or the kidney
or liver anomalies, reinforcing the notion of clinical spec-
trum and/or overlap among ciliary phenotypes.
Pleiotropic effects of CEP290 mutations are even more
striking, since CEP290 mutations were recently shown to
be a frequent cause of isolated LCA.10 A genotype-pheno-
type correlation was suggested, since all LCA-affected pa-
tients of the study of den Hollander et al.10 carried the
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Figure 3. Sequence chromatographs of CEP290 mutations identified in the present study. Mutation numbering is based on cDNA
sequence, where 1 corresponds to the A of the ATG translation codon in the GenBank cDNA reference sequence NM_025114.3. The
predicted effect of the mutation on the protein is also given with the amino acid number.
same intronic mutation located in intron 26 (c.2991
1655ArG) leading to an aberrant transcript and prema-
ture stop codon. Patients were either homozygous for this
mutation and retained some normal transcript or were
compound heterozygous for another CEP290 mutation.
The 2991644ArG mutation is found exclusively in pa-
tients with LCA, although a recent study identified pa-
tients with LCA with two truncating CEP290 mutations
but not the intron 26 mutation.11 No other genotype-phe-
notype correlations have been observed for CEP290 mu-
tations leading to JS, MKS, or LCA phenotypes. All CEP290
mutations reported so far are truncating in all three phe-
notypes, except for two missense mutations reported in
two patients with JS: p.W7C20 and p.A1991G.21 TMEM67
Figure 4. Pathological features of fetal cases with CEP290 mutations. Histological sections (HES staining) of kidney (left), liver
(middle), and brain stem/cerebellum (right) of MKS- and MKS-like–affected fetuses with CEP290 mutations. In families 1–4 (a–d) and
10 (m), kidney histology shows major abnormalities characteristic of MKS: cysts in both kidney and medulla, growing from periphery
to center. Small areas of conserved nephrogenesis are observed in the subcapsular zone. In family 9 (l), kidney histology shows conserved
corticomedullary organization with several generations of mature glomeruli. Microcysts are found in the deep cortex, but tubular
microcysts are observed mainly in medulla (black arrows). Liver histology shows a portal fibrosis with persistent ductal plate (arrows)
and/or BDP/dilatation (arrowheads). Subject 4 (b) had the most-severe liver fibroadenomatosis, whereas the liver anomalies were
moderate and focal in families 9 (n) and 10 (o). Brain-stem/cerebellum transverse sections are shown for five cases. i, Subject 4: section
of the mesencephalon showing the chaotic organization of fibers and tracts (arrows) and atretic aqueduct of Sylvius. j, Subject 3501:
section at the level of the pons showing severely dilated V4, enlarged cerebellar peduncle (P), chaotic organization of fibers and tracts
(arrows), hypoplastic vermis (arrowhead), and cerebellar hemispheres (ce). k, Fetus 304. Note the inverted MTS with dysmorphic V4
flanked with enlarged and elongated cerebellar peduncles (P). For fetuses 381 (p) and 03/485 (q), the section at the level of the pons
shows an inverted MTS with chaotic fibers and tracts (arrows), dysmorphic V4, severe hypoplasia of vermis (arrowhead), and well-
developed cerebellar hemispheres. Fampfamily.
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mutations are either truncating or missense in both JS and
MKS.19 Further functional analyses are needed to clarify
whether the nature of the mutations is responsible for
the variable clinical spectrum observed with CEP290 or
TMEM67 mutations. However, the existence of both phe-
notypes in siblings—or the same mutation leading to
different phenotypes—argues against this hypothesis for
CEP290. In view of the oligogenic inheritance and epi-
static mutations already reported for JS21 and BBS,24,25 mu-
tations/polymorphisms in other ciliary protein–encoding
genes is a tantalizing alternative hypothesis. In family
10, we identified only one CEP290 nonsense mutation
(p.Q662X) inherited from the father and two fetuses that
were haploidentical at the locus; we may have failed to
find the maternal CEP290 molecular event. The other pos-
sibility, within the context of oligogenism, is that the re-
cessive mutation is in another gene. However, we failed
to find any mutations in the MKS1, TMEM67, or BBS1–
BBS10 genes in this family.
Along the same line, it is noteworthy that, in family 1,
originating from Morocco (fig. 1c), two distinct ciliopa-
thies segregated in the kindred—namely, autosomal reces-
sive polycystic kidney disease (ARPKD) (in the first child
and fetus 6) and JS/MKS (in fetuses 5 and 6). The diagno-
sis of ARPKD was confirmed through kidney and liver his-
tology. The CEP290 p.R205X mutation was found at the
homozygous state only in siblings 5 and 6 with the MKS
phenotype. The PKHD1 locus showed homozygosity in
subject 6 with ARPKD, compatible with a homozygous
PKHD1 mutation. Interestingly, homozygosity at the
PKHD1 locus was also observed in subject 4 with MKS,
who had the most-severe kidney and liver phenotypes.
MKS is genetically and clinically heterogeneous. MKS1
gene mutations were identified only in fetuses with the
complete spectrum of MKS,1 and, in a recent series, half
of the fetuses had skeletal dysplasia with long-bone bow-
ing or IUGR,5 a feature that was not observed in TMEM67-
mutated fetuses and was present only in 1 of 21 siblings
of our series with CEP290 mutations. PD was much more
frequent in MKS1-affected fetuses than in those with the
TMEM67 mutation and remains rare in CEP290-mutated
fetuses (3 of 10 families; 8 of 20 fetuses). Since MKS1 mu-
tations were not identified in fetuses with either MKS-like
or postnatal JS,19 one can hypothesis that MKS is at the
very end of the spectrum of another human disorder. Hy-
pomorphic MKS1 mutations could cause another human
ciliopathy in which, unlike JS, PD would be a frequent
sign. In favor of this hypothesis, all MKS1 mutations iden-
tified so far in MKS predict a truncated protein. The allelic
nature of MKS and JS conditions may be extended to the
MKS2 locus, which has been mapped to chromosome
11q134 and may therefore be allelic to CORS2, which has
been mapped to 11p12-11q13.3.18 Indeed, whereas no
organ involvement is described in patients with linkage
to JBTS1 on chromosome 9, a large variability is associ-
ated with JBTS2-linked patients, with multivisceral in-
volvement, including OE, PD, microphthalmia, and kid-
ney involvement.26
This study identifies a fourth locus for MKS (MKS4) and
the CEP290 gene on chromosome 12 as responsible for
MKS. These data also further confirm the allelism be-
tween JS and MKS and extend the phenotypic spectrum
of CEP290 mutations already involved in JS and isolated
LCA to a severe and lethal cystic kidney dysplasia with
BDP of liver and neural-tube defects. Further studies will
tell whether other genes might be responsible for both
phenotypes and whether MKS might also represent the
most severe, lethal end of the spectrum of other human
ciliopathies.
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